Patent details
300604
Product Name:
Combinatie van Neisseria meningitidis groep B NHBA-fusie-eiwit; Neisseria meningitidis groep B NadA-eiwit; en Neisseria meningitidis groep B fHbp-fusie-eiwit
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300604
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1549338
Status:
SPC in force
Application number:
300604
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
Marketing Authorization Number:
EU/1/12/812/001-004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/01/2013
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
15/07/2013
First Marketing Authorization date:
18/01/2013
Grant date:
22/09/2016
Activation date:
02/10/2023
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
15/07/2013
SPC/SPC Extension Expiration Date:
17/01/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
22/12/2021
Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Historical Applicant/holder
From:
29/07/2014
To:
22/12/2021
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
From:
15/07/2013
To:
29/07/2014
Name:
Novartis Vaccines and Diagnostics S.r.l.
Address:
Via Fiorentina 1, 53100 SIENA (SI), Italy (IT)
Agent
Name:
ir. F.A. Geurts c.s.
From:
21/02/2018
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
40/23
Publication date:
04/10/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
CO
Journal edition number:
05/22
Publication date:
02/02/2022
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
CO
Journal edition number:
2014/39
Publication date:
24/09/2014
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
SPC
Journal edition number:
2013/31
Publication date:
31/07/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102715A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
022527-A022527-1
Date Registered:
29/07/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Other
Note:
Annual Fee
Annual Fee(s) Due Date:
31/10/2025
Annual Fee Number:
23
Annual Fee Amount:
2000 Euro
Last Annual Payment Date:
19/09/2024
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Anaqua Services
Filing date
Document type
Document Description
Number of pages
File Type
19/02/2018
Incoming Correspondence Paper
Correspondence address details
1
PDF
/4/0/6/0/0/0400300604/docs/300604_14_incomingcorrespondencepaper20180221113415474.pdf
17/11/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/4/0/6/0/0/0400300604/docs/300604_12_outgoingcorrespondence20161118092946039.pdf
17/11/2016
SPC Documents
Certificate SPC
1
PDF
/4/0/6/0/0/0400300604/docs/300604_13_supplprotectioncertificate20161118092946110.pdf
04/11/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/4/0/6/0/0/0400300604/docs/300604_4_incomingcorrespondencepaper20161107033700172.pdf
22/09/2016
SPC Documents
Certificate SPC
1
PDF
/4/0/6/0/0/0400300604/docs/300604_9_supplprotectioncertificate20201008103019471.pdf
22/09/2016
SPC Documents
Decision SPC
1
PDF
/4/0/6/0/0/0400300604/docs/300604_10_supplprotectioncertificate20201008104010217.pdf
22/06/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/4/0/6/0/0/0400300604/docs/300604_2_incomingcorrespondencepaper20160627040314094.pdf
22/06/2016
SPC Documents
Annex SPC
1
PDF
/4/0/6/0/0/0400300604/docs/300604_7_supplprotectioncertificate20201008104302044.pdf
03/06/2014
Incoming Correspondence Paper
Accompanying letter incoming document
6
PDF
/4/0/6/0/0/0400300604/docs/300604_6_incomingcorrespondencepaper20140603.pdf
20/03/2014
Outgoing Correspondence
Outgoing Letter
2
PDF
/4/0/6/0/0/0400300604/docs/300604_1_outgoingcorrespondence20140320.pdf
22/07/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/4/0/6/0/0/0400300604/docs/300604_3_outgoingcorrespondence20130722.pdf
19/07/2013
Application Form
First filed application form
4
PDF
/4/0/6/0/0/0400300604/docs/300604_0_applicationform20130719.pdf
19/07/2013
SPC Documents
Summary of the characteristics of the product
31
PDF
/4/0/6/0/0/0400300604/docs/300604_5_supplprotectioncertificate20201008104741447.pdf
19/07/2013
SPC Documents
Marketing Authorization SPC
3
PDF
/4/0/6/0/0/0400300604/docs/300604_8_supplprotectioncertificate20201008104610290.pdf
19/07/2013
SPC Documents
Marketing Authorization SPC
4
PDF
/4/0/6/0/0/0400300604/docs/300604_11_supplprotectioncertificate20201008104937193.pdf